LU21: a New High-frequency Antigen in the Lutheran Blood Group SystemCrew · Vox Sanguinis2004PDF131 KB
A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11)Kim · Clinical Lung Cancer2022PDF326 KB
Ifosfamide, Carboplatin, and Etoposide With Midcycle Vincristine Versus Standard Chemotherapy in Patients With Small-Cell Lung Cancer and Good Performance Status: Clinical and Quality-of-Life Results of the British Medical Research Council Multicenter Randomized LU21 TrialThatcher · American Society of Clinical Oncology2005PDF196 KB
O-275 Ifosfamide, Carboplatin and Etoposide with Mid-cycle Vincristine (ICE-V) Versus Standard Chemotherapy (C) in Patients with Small Cell Lung Cancer (SCLC) and Good Performance Status (PS): Results of an MRC Randomized Trial (LU21)Thatcher · Lung Cancer2003PDF139 KB
